| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443841 | European Journal of Cancer | 2014 | 7 Pages |
Abstract
Our preliminary case series data suggest limited activity of enzalutamide in the post-docetaxel and post-abiraterone patient population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
D. Bianchini, D. Lorente, A. Rodriguez-Vida, A. Omlin, C. Pezaro, R. Ferraldeschi, A. Zivi, G. Attard, S. Chowdhury, J.S. de Bono,